149 related articles for article (PubMed ID: 37470440)
1. Comprehensive profiling identifies tumour and immune microenvironmental differences in clinical subsets of cutaneous squamous cell carcinoma.
Thai AA; Young RJ; Bressel M; Angel C; McDowell L; Tiong A; Bucknell NW; Fellowes A; Xu H; Trigos A; Rischin D; Solomon BJ
Br J Dermatol; 2023 Oct; 189(5):588-602. PubMed ID: 37470440
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
Levine DE; Karia PS; Schmults CD
JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
[TBL] [Abstract][Full Text] [Related]
4. HLA expression as a risk factor for metastases of cutaneous squamous-cell carcinoma in organ- transplant recipients.
de Jong E; Quint KD; El Ghalbzouri A; Verdijk RM; Goeman JJ; Heidt S; Claas FHJ; de Fijter JW; Genders RE; Vermeer MH; Bouwes Bavinck JN
Hum Immunol; 2023 Mar; 84(3):208-213. PubMed ID: 36621381
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of advanced cutaneous squamous cell carcinoma.
Dessinioti C; Pitoulias M; Stratigos AJ
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):39-50. PubMed ID: 34592000
[TBL] [Abstract][Full Text] [Related]
6. Identification of genetic mutations of cutaneous squamous cell carcinoma using whole exome sequencing in non-Caucasian population.
Lee SY; Lee M; Yu DS; Lee YB
J Dermatol Sci; 2022 May; 106(2):70-77. PubMed ID: 35365379
[TBL] [Abstract][Full Text] [Related]
7. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
[TBL] [Abstract][Full Text] [Related]
8. Genomic and transcriptomic analysis of cutaneous squamous cell carcinoma arising in immunocompetent and immunosuppressed patients.
Bibee KP; Kulkarni A; Lee S; Ho J; Osmanbeyoglu HU; Ferris RL; Zandberg DP
Oral Oncol; 2024 Jan; 148():106582. PubMed ID: 38039877
[TBL] [Abstract][Full Text] [Related]
9. Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas.
Föll MC; Fahrner M; Gretzmeier C; Thoma K; Biniossek ML; Kiritsi D; Meiss F; Schilling O; Nyström A; Kern JS
Matrix Biol; 2018 Mar; 66():1-21. PubMed ID: 29158163
[TBL] [Abstract][Full Text] [Related]
10. FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma.
Bernat-Peguera A; Navarro-Ventura J; Lorenzo-Sanz L; da Silva-Diz V; Bosio M; Palomero L; Penin RM; Pérez Sidelnikova D; Bermejo JO; Taberna M; Vilariño N; Piulats JM; Mesia R; Viñals JM; González-Suárez E; Capella-Gutierrez S; Villanueva A; Viñals F; Muñoz P
Clin Cancer Res; 2021 Mar; 27(5):1491-1504. PubMed ID: 33262138
[TBL] [Abstract][Full Text] [Related]
11. Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma.
Szewczyk M; Pazdrowski J; Golusiński P; Dańczak-Pazdrowska A; Marszałek S; Golusiński W
Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):3007-12. PubMed ID: 25217080
[TBL] [Abstract][Full Text] [Related]
12. Cumulative incidence and timing of subsequent cutaneous squamous cell carcinomas stratified for patients with organ transplantation and hematologic malignancies: A nationwide cohort study.
Eggermont CJ; Hollestein LM; Hollatz A; Louwman M; Mooyaart AL; Nijsten T; Wakkee M
J Am Acad Dermatol; 2024 Mar; 90(3):530-536. PubMed ID: 37871807
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study.
Knuutila JS; Riihilä P; Kurki S; Nissinen L; Kähäri VM
Acta Derm Venereol; 2020 Sep; 100(16):adv00266. PubMed ID: 32930344
[TBL] [Abstract][Full Text] [Related]
14. Clinical and histopathological evaluation of 50 acantholytic cutaneous squamous cell carcinomas: Analysis outcome in a retrospective case-control study.
Conde-Ferreirós A; Moyano-Bueno D; Santos-Briz Á; Revelles-Peñas L; Revilla-Nebreda D; Becerril-Andrés S; Román-Curto C; Cañueto J
J Cutan Pathol; 2022 Feb; 49(2):133-138. PubMed ID: 34363705
[TBL] [Abstract][Full Text] [Related]
15. Identification of proteins associated with development of metastasis from cutaneous squamous cell carcinomas (cSCCs) via proteomic analysis of primary cSCCs.
Shapanis A; Lai C; Smith S; Coltart G; Sommerlad M; Schofield J; Parkinson E; Skipp P; Healy E
Br J Dermatol; 2021 Apr; 184(4):709-721. PubMed ID: 32794257
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of stromal periostin correlates with poor prognosis of cutaneous squamous cell carcinomas.
Lincoln V; Chao L; Woodley DT; Murrell D; Kim M; O'Toole EA; Ly A; Cogan J; Mosallaei D; Wysong A; Chen M
Exp Dermatol; 2021 May; 30(5):698-704. PubMed ID: 33450077
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA31 and MMP-1 contribute to the differentiated pathway of invasion -with enhanced epithelial-to-mesenchymal transition- in squamous cell carcinoma of the skin.
Fernández-Figueras MT; Carrato C; Saenz-Sardà X; Musulén E; Fuente MJ; Puig L
Arch Dermatol Res; 2022 Oct; 314(8):767-775. PubMed ID: 34647185
[TBL] [Abstract][Full Text] [Related]
19. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous Squamous Cell Carcinoma: From Biology to Therapy.
Corchado-Cobos R; García-Sancha N; González-Sarmiento R; Pérez-Losada J; Cañueto J
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
